Skip to search formSkip to main contentSkip to account menu

MDV9300

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

pidilizumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
HG-02A PHASE 1/2 TRIAL OF THE ANTIBODY PIDILIZUMAB (MDV9300) IN PEDIATRIC DIFFUSE INTRINSIC PONTINE GLIOMA
2015
2015
First Interim Results of a Phase I/II Study of Lenalidomide in Combination with Anti-PD-1 Monoclonal Antibody MDV9300 (CT-011) in Patients with Relapsed/Refractory Multiple Myeloma
Introduction: Multiple myeloma (MM) is associated with profound and widespread disarray of both the adaptive and innate arms of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)